Bookmark

Add to MyYahoo RSS

Covance News

News on Covance (Ticker: CVD) continually updated from thousands of sources around the net.

22 hrs ago | AmericanBankingNews.com

Covance Given Average Rating of "Hold" by Analysts

Covance has earned a consensus rating of "Hold" from the fifteen brokerages that are presently covering the stock, Analyst RN reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Apr 10, 2014

AmericanBankingNews.com

Jefferies Group Increases Covance Price Target to $117.00

The firm currently has a "buy" rating on the stock. Jefferies Group's target price indicates a potential upside of 14.89% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Apr 03, 2014

BioSpace

Covance Inc. Invites You To Join The Webcast Of Its First Quarter...

Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Covance

Tue Mar 25, 2014

BioSpace

Covance Inc. Expands Global Biologics Capabilities

March 25, 2014 - Covance Inc. , one of the world's largest and most comprehensive drug development services companies, today announced that it is building on its expertise in biologics development with new investments to meet growing client demand, including the expansion of its global bioanalytical footprint and the addition of scientific leaders ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Covance

Thu Mar 06, 2014

AmericanBankingNews.com

Covance Sets New 12-Month High at $105.08

Shares of Covance hit a new 52-week high during trading on Thursday , AR Network reports.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••